Updated Jul 16, 2026
GRAY SUSANNAH has filed 4 SEC Form 4 filings across 4 companies in the last 90 days.
Susannah Gray is associated with AnaptysBio, Inc., a biotechnology company focused on developing antibody therapeutics for the treatment of various diseases. Specific details about her role and contributions are limited, indicating she may not be a widely recognized figure in the industry.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | tbph | Theravance Biopharma, Inc. | A — Grant or award | 6.0K | $0.00 | |
| 2026-05-28 | MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | A — Grant or award | 46.3K | $0.00 |
Susannah Gray is associated with AnaptysBio, Inc., a biotechnology company focused on developing antibody therapeutics for the treatment of various diseases. Specific details about her role and contributions are limited, indicating she may not be a widely recognized figure in the industry.…
4 primary Form 4 filings in the last 90 days, covering 4 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GRAY SUSANNAH profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.